ZELSUVMI

Growth

berdazimer

NDATOPICALGEL
Approved
Jan 2024
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Jul 10, 2035
113 months away
Patent Expiry
Jul 10, 2035
Exclusivity Expiry
Jan 5, 2029

Patent Records (5)

Patent #ExpiryTypeUse Code
8956658
May 30, 2026
Substance
—
8282967
May 30, 2026
Substance
—
9737561
Aug 20, 2030
U-3802
10376538
Aug 20, 2030
Product
—
9526738
Sep 3, 2031
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers